AVXL · Anavex Life Sciences Corp. · Executive Compensation

$1.29 -0.07 (-5.15%)

Russell 2000 member Rebalance outlook locked

Market Cap

$120.97M

92.70M

Volume · Oct 23 627.22K Avg daily vol (3M) 1.03M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer and Director	$700,000	$140,000	—	$1,927,600	—	$16,100	$2,783,700
Sandra Boenisch	Principal Financial Officer and Treasurer	$201,468	—	—	$192,700	—	$8,059	$402,227

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer and Director	$700,000	$124,753	—	$3,066,200	—	$3,500	$3,894,453
Sandra Boenisch	Principal Financial Officer and Treasurer	$186,883	—	—	$306,700	—	$7,475	$501,058

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer and Director	$586,400	$110,000	—	$6,045,043	—	$12,200	$6,753,643
Sandra Boenisch	Principal Financial Officer and Treasurer	$174,900	—	—	$277,603	—	—	$452,503

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer, and Director	$550,000	$110,000	—	$8,745,457	—	$11,600	$9,417,057
Sandra Boenisch	Principal Financial Officer and Treasurer	$158,300	—	—	$724,314	—	—	$882,614

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer, and Director	$550,000	$55,000	—	$1,224,648	—	$11,400	$1,841,048
Sandra Boenisch	Principal Financial Officer and Treasurer	$117,041	$22,313	—	$155,864	—	—	$295,218

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer, and Director	$512,500	$50,000	—	$2,806,339	—	$11,200	$3,380,039
Sandra Boenisch	Principal Financial Officer and Treasurer	$72,327	$13,561	—	$138,672	—	—	$224,560

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Christopher Missling	President, Chief Executive Officer, and Director	$500,000	$65,000	—	$1,973,889	—	$11,000	$2,549,889
Sandra Boenisch	Principal Financial Officer and Treasurer	$79,608	$11,414	—	$141,047	—	—	$232,069

Executive changes

Person	Role	Change	Effective	Filed
Terrie Kellmeyer, PhD	Interim Chief Executive Officer	Appointed	2026-05-04	2026-05-06
Christopher Missling, PhD	Chief Executive Officer	Terminated	2026-04-30	2026-05-06
Axel Paeger	member of the Board	Appointed	2026-02-23	2026-02-25
Steffen Thomas, PhD	director	Appointed	2025-06-10	2025-06-13
Peter Donhauser, D.O.	director	Appointed	2025-06-10	2025-06-13
Athanasios Skarpelos	director	Appointed	2025-06-10	2025-06-13
Claus van der Velden, PhD	director	Appointed	2025-06-10	2025-06-13
Jiong Ma, PhD	director	Appointed	2025-06-10	2025-06-13
Christopher Missling, PhD	director	Appointed	2025-06-10	2025-06-13

Leadership

Terrie Kellmeyer, PhD CEO
Athanasios Skarpelos Board Member
Axel Paeger Board Member
Christopher Missling, PhD Board Member
Claus van der Velden, PhD Board Member
Jiong Ma, PhD Board Member
Peter Donhauser, D.O. Board Member
Steffen Thomas, PhD Board Member

Key facts CIK 1314052 CUSIP 032797300 13F (30d) 25 filings 25 filers Visit website Investor relations